Home » Authors » Trista Morrison

Articles by Trista Morrison

Acorda Raises $67 Million For Second Fampridine-SR Phase III

June 11, 2007

By Trista Morrison

Acorda Raises $67 Million For Second Fampridine-SR Phase III

June 11, 2007

By Trista Morrison

NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes

June 11, 2007

By Trista Morrison

Amylin Sells $575 Million Of Convertible Senior Notes

June 7, 2007

By Trista Morrison

FDA Halts Telcyta Program On Heels Of ASCO Data

June 6, 2007

By Trista Morrison

FDA Halts Telcyta Program On Heels Of ASCO Data

June 6, 2007

By Trista Morrison

Telik Falls On Details Of Its Failed Phase III Telcyta Trials

June 5, 2007

By Trista Morrison

Telik Falls On Details Of Its Failed Phase III Telcyta Trials

June 5, 2007

By Trista Morrison

NewCo News: Indigo Licenses PAD Drug, Preps For Phase III Trials

June 4, 2007

By Trista Morrison

NewCo News: Indigo Licenses PAD Drug, Preps For Phase III Trials

June 4, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.